2-5 DECEMBER 2018:
EUROGIN 2018, INTERNATIONAL MULTIDISIPLINARY HPV CONGRESS
“A risk-based approach: co-testing 34,612 women with cytology and a 3-type HPV mRNA test”
MD.PhD S.W.Sørbye
“Primary cervical screening with a 5-type HPV E6/E7 mRNA test: Results of 10 years follow-up”
Prof. MD. F.E.Skjeldestad
“3-type HPV mRNA test in detection of CIN2+ in young women with normal cytology“
MD. K. Al-Shibli
“Is co-testing with a 3-type HPV MRNA test a better strategy for women 21-29 years than cytology only?“
MD.PhD S.W.Sørbye
“The added value of rescreening cytology normal samples with positive HPV mRNA test for the detection of CIN2+ in primary screening”
Prof. MD. F.E.Skjeldestad
